Investing.com - Astrana Health (NASDAQ: ASTH) reported fourth quarter EPS of $0.26, $0.11 better than the analyst estimate of $0.15. Revenue for the quarter came in at $353.04M versus the consensus estimate of $337.31M.
Astrana Health's stock price closed at $43.54. It is up 25.11% in the last 3 months and up 24.76% in the last 12 months.
Astrana Health saw 1 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Astrana Health's stock price’s past reactions to earnings here.
According to InvestingPro, Astrana Health's Financial Health score is "great performance".
Check out Astrana Health's recent earnings performance, and Astrana Health's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar